header-logo header-logo

11 October 2013
Issue: 7579 / Categories: Case law , Law digest , In Court
printer mail-detail

Company law

Re Sigma-Tau Pharma Ltd and another [2013] All ER (D) 31 (Oct)

The issue for consideration was whether the court should approve the cross-border merger. Consideration was given to reg 16 of the Companies (Cross Border Mergers) Regulations 2007 (SI 2007/2974). The court ruled that it was settled law that, in assessing whether to complete a merger, the court had to examine the proposed merger and be satisfied that it did not affect any stakeholder in any of the merging companies, including shareholders, employees or creditors, in any material way, and be satisfied that there was not any other good reason why the approval should be refused. The fact that a pre-merger certificate had been issued by another country did not remove the requirement for the court to scrutinize the merger.

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit LLP—Caroline Williams

Jurit LLP—Caroline Williams

Private wealth and tax team welcomes cross-border specialist as consultant

Freeths—Michelle Kirkland Elias

Freeths—Michelle Kirkland Elias

International hospitality and leisure specialist joins corporate team as partner

Flint Bishop—Deborah Niven

Flint Bishop—Deborah Niven

Firm appoints head of intellectual property to drive northern growth

NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
back-to-top-scroll